Krebs Biochemicals and Industries profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 11.0% | 11.0% | 20.3% | 18.0% | 28.3% | ||
| −10.2% | −10.2% | −15.5% | −11.2% | −13.5% | ||
| −20.5% | −20.5% | −23.9% | −12.8% | −18.8% | ||
| −14.9% | −19.2% | −33.0% | −20.9% | −26.7% | ||
Margins | ||||||
| −6.2% | −23.0% | −34.7% | −17.3% | −30.3% | ||
| −50.0% | −50.0% | −50.1% | −30.7% | −42.9% | ||
| — | −50.3% | 87.6% | −399.8% | — | ||
| −49.7% | −71.4% | −62.2% | −39.1% | −47.4% | ||
| −49.7% | −71.4% | −62.2% | −39.1% | −47.4% | ||
| −25.0% | −25.0% | −30.1% | −10.9% | −71.7% | ||
Additional | ||||||
| 0.0% | 0.0% | −0.1% | 0.0% | 0.0% | ||
| 11.0% | 11.0% | 20.3% | 18.0% | 28.3% | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.